\
&
Contact us
\
&
Contact us
Despite serious efforts deployed at national and European level, the European Union sees significant internal disparities in terms of research and innovation performance. There is significant evidence pointing to the fact that the pathway to economic growth and competitiveness is strongly connected to the scaling up of investment in research and innovation.
In order to reduce the research and innovation gap, Horizon 2020 introduces specific measures for spreading excellence and widening participation. These measures are targeted at low-performing Member States in terms of research and innovation.
Widening consists of three main actions, i.e. Teaming, Twinning and ERA Chairs, for which specific eligibility conditions apply. This ensures a targeted approach towards Widening Member States and Associated Countries.
The Widening member states are: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovakia and Slovenia.
Belgium is not identified as a Widening Member State but can partake as partner.
manhei.to@fwo.be
+32 2 550 15 55
Find the contact info on the site of WEWIS
The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.
The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
